BAXTER/GENETICS INSTITUTE’s RECOMBINATE ANTIHEMOPHILIC FACTOR APPROVED BY FDA DEC. 10; FIRST LICENSED rFACTOR VIII PRODUCT WILL BEGIN SHIPPING DEC. 21